These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

280 related items for PubMed ID: 11439364

  • 1. Detailed deletion mapping in sporadic breast cancer at chromosomal region 17p13 distal to the TP53 gene: association with clinicopathological parameters.
    Seitz S, Poppe K, Fischer J, Nothnagel A, Estévez-Schwarz L, Haensch W, Schlag PM, Scherneck S.
    J Pathol; 2001 Jul; 194(3):318-26. PubMed ID: 11439364
    [Abstract] [Full Text] [Related]

  • 2. Loss of heterozygosity is detected at chromosomes 1p35-36 (NB), 3p25 (VHL), 16p13 (TSC2/PKD1), and 17p13 (TP53) in microdissected apocrine carcinomas of the breast.
    Lininger RA, Zhuang Z, Man Y, Park WS, Emmert-Buck M, Tavassoli FA.
    Mod Pathol; 1999 Dec; 12(12):1083-9. PubMed ID: 10619258
    [Abstract] [Full Text] [Related]

  • 3. Loss of heterozygosity at 17p13.3-ter, distal to TP53, correlates with negative hormonal phenotype in sporadic breast cancer.
    Roncuzzi L, Brognara I, Baiocchi D, Amadori D, Gasperi-Campani A.
    Oncol Rep; 2005 Aug; 14(2):471-4. PubMed ID: 16012732
    [Abstract] [Full Text] [Related]

  • 4. Prognostic significance of loss of heterozygosity at loci on chromosome 17p13.3-ter in sporadic breast cancer is evidence for a putative tumour suppressor gene.
    Liscia DS, Morizio R, Venesio T, Palenzona C, Donadio M, Callahan R.
    Br J Cancer; 1999 May; 80(5-6):821-6. PubMed ID: 10360661
    [Abstract] [Full Text] [Related]

  • 5. Evidence for a gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumors without p53 mutations.
    Cornelis RS, van Vliet M, Vos CB, Cleton-Jansen AM, van de Vijver MJ, Peterse JL, Khan PM, Børresen AL, Cornelisse CJ, Devilee P.
    Cancer Res; 1994 Aug 01; 54(15):4200-6. PubMed ID: 8033152
    [Abstract] [Full Text] [Related]

  • 6. High incidence of loss of heterozygosity at chromosome 17p13 in breast tumours from BRCA2 mutation carriers.
    Eiriksdottir G, Barkardottir RB, Agnarsson BA, Johannesdottir G, Olafsdottir K, Egilsson V, Ingvarsson S.
    Oncogene; 1998 Jan 08; 16(1):21-6. PubMed ID: 9467939
    [Abstract] [Full Text] [Related]

  • 7. [Loss of heterozygosity fine mapping of chromosome 17p13 in transitional cell carcinoma of human urinary bladder].
    Zheng S, Zhang J, Di X, Xiao Z, Wang D, Li C, He Z, Han N, Guo S, Cheng S, Gao Y.
    Zhonghua Yi Xue Za Zhi; 2002 Feb 10; 82(3):161-3. PubMed ID: 11953150
    [Abstract] [Full Text] [Related]

  • 8. Consortium study on 1280 breast carcinomas: allelic loss on chromosome 17 targets subregions associated with family history and clinical parameters.
    Phelan CM, Borg A, Cuny M, Crichton DN, Baldersson T, Andersen TI, Caligo MA, Lidereau R, Lindblom A, Seitz S, Kelsell D, Hamann U, Rio P, Thorlacius S, Papp J, Olah E, Ponder B, Bignon YJ, Scherneck S, Barkardottir R, Borresen-Dale AL, Eyfjörd J, Theillet C, Thompson AM, Larsson C.
    Cancer Res; 1998 Mar 01; 58(5):1004-12. PubMed ID: 9500463
    [Abstract] [Full Text] [Related]

  • 9. Alterations of the 16q22.1 and 16q24.3 chromosomal loci in sporadic invasive breast carcinomas: correlation with proliferative activity, ploidy and hormonal status of the tumors.
    Kouvaraki M, Gorgoulis VG, Rassidakis GZ, Liodis P, Koutroumbi E, Markopoulos C, Gogas J, Kittas C.
    Anticancer Res; 2001 Mar 01; 21(2A):991-9. PubMed ID: 11396193
    [Abstract] [Full Text] [Related]

  • 10. Papillary lesions of the breast: a molecular progression?
    Di Cristofano C, Mrad K, Zavaglia K, Bertacca G, Aretini P, Cipollini G, Bevilacqua G, Ben Romdhane K, Cavazzana A.
    Breast Cancer Res Treat; 2005 Mar 01; 90(1):71-6. PubMed ID: 15770529
    [Abstract] [Full Text] [Related]

  • 11. A region close to Tp53 shows LOH in familial breast cancer.
    Luo L, Chen J, Du Q, Dumanski J, Blennow E, Kockum I, Luthman H, Lindblom A.
    Int J Mol Med; 2002 Apr 01; 9(4):405-9. PubMed ID: 11891537
    [Abstract] [Full Text] [Related]

  • 12. Loss of heterozygosity in sporadic human breast carcinoma: a common region between 11q22 and 11q23.3.
    Hampton GM, Mannermaa A, Winqvist R, Alavaikko M, Blanco G, Taskinen PJ, Kiviniemi H, Newsham I, Cavenee WK, Evans GA.
    Cancer Res; 1994 Sep 01; 54(17):4586-9. PubMed ID: 8062246
    [Abstract] [Full Text] [Related]

  • 13. Detailed deletion mapping suggests the involvement of a tumor suppressor gene at 17p13.3, distal to p53, in the pathogenesis of lung cancers.
    Konishi H, Takahashi T, Kozaki K, Yatabe Y, Mitsudomi T, Fujii Y, Sugiura T, Matsuda H, Takahashi T, Takahashi T.
    Oncogene; 1998 Oct 22; 17(16):2095-100. PubMed ID: 9798680
    [Abstract] [Full Text] [Related]

  • 14. Pancreatic endocrine tumours: evidence for a tumour suppressor pathogenesis and for a tumour suppressor gene on chromosome 17p.
    Beghelli S, Pelosi G, Zamboni G, Falconi M, Iacono C, Bordi C, Scarpa A.
    J Pathol; 1998 Sep 22; 186(1):41-50. PubMed ID: 9875139
    [Abstract] [Full Text] [Related]

  • 15. Pattern of gene alterations in intraductal breast neoplasms associated with histological type and grade.
    Tsuda H, Fukutomi T, Hirohashi S.
    Clin Cancer Res; 1995 Mar 22; 1(3):261-7. PubMed ID: 9815981
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Molecular genetic evidence for the independent origin of multifocal papillary tumors in patients with papillary renal cell carcinomas.
    Jones TD, Eble JN, Wang M, MacLennan GT, Delahunt B, Brunelli M, Martignoni G, Lopez-Beltran A, Bonsib SM, Ulbright TM, Zhang S, Nigro K, Cheng L.
    Clin Cancer Res; 2005 Oct 15; 11(20):7226-33. PubMed ID: 16243792
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.